NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics

The prevalence of osteoarthritis (OA) notably surges with age and weight gain. The most common clinical therapeutic drugs are painkillers, yet they cannot impede the deteriorating course of OA. Thus, understanding OA’s pathogenesis and devising effective therapies is crucial. It is generally recogni...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuzhou Liu, Ying Wang, Ping Yan, Ning Cui, Kejin Xu, Da Liu, Yuan Tian, Lingling Cao
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Biology
Subjects:
Online Access:https://www.mdpi.com/2079-7737/14/1/71
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589030294814720
author Yuzhou Liu
Ying Wang
Ping Yan
Ning Cui
Kejin Xu
Da Liu
Yuan Tian
Lingling Cao
author_facet Yuzhou Liu
Ying Wang
Ping Yan
Ning Cui
Kejin Xu
Da Liu
Yuan Tian
Lingling Cao
author_sort Yuzhou Liu
collection DOAJ
description The prevalence of osteoarthritis (OA) notably surges with age and weight gain. The most common clinical therapeutic drugs are painkillers, yet they cannot impede the deteriorating course of OA. Thus, understanding OA’s pathogenesis and devising effective therapies is crucial. It is generally recognized that inflammation, <i>pyroptosis</i>, and OA progression are tightly linked. The activation of NLRP3 inflammasome can lead to the discharge of the pro-inflammatory cytokines Interleukin-1β and IL-18, intensifying subsequent inflammatory reactions and promoting OA development. Conversely, the imbalance caused by deacetylase-regulated NLRP3 inflammasome underlies the chronic mild inflammation related to degenerative diseases. Therefore, this article expounds on the mechanism of OA pathogenesis and the role of histone deacetylases (HDACs) in NLRP3 inflammasome-triggered OA, and illustrates the application of HDAC inhibitors in OA, striving to provide more insights into novel OA treatment approaches.
format Article
id doaj-art-21c44d322e954e6c9b798547e635f8f2
institution Kabale University
issn 2079-7737
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Biology
spelling doaj-art-21c44d322e954e6c9b798547e635f8f22025-01-24T13:23:31ZengMDPI AGBiology2079-77372025-01-011417110.3390/biology14010071NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of EpigeneticsYuzhou Liu0Ying Wang1Ping Yan2Ning Cui3Kejin Xu4Da Liu5Yuan Tian6Lingling Cao7School of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, ChinaSchool of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, ChinaCollege of Traditional Chinese Medicine, Changchun University of Traditional Chinese Medicine, Changchun 130117, ChinaCollege of Traditional Chinese Medicine, Changchun University of Traditional Chinese Medicine, Changchun 130117, ChinaSchool of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, ChinaPublic Laboratory Centre, Changchun University of Chinese Medicine, Changchun 130117, ChinaClinical School of Medicine, Changchun University of Traditional Chinese Medicine, Changchun 130117, ChinaClinical School of Medicine, Changchun University of Traditional Chinese Medicine, Changchun 130117, ChinaThe prevalence of osteoarthritis (OA) notably surges with age and weight gain. The most common clinical therapeutic drugs are painkillers, yet they cannot impede the deteriorating course of OA. Thus, understanding OA’s pathogenesis and devising effective therapies is crucial. It is generally recognized that inflammation, <i>pyroptosis</i>, and OA progression are tightly linked. The activation of NLRP3 inflammasome can lead to the discharge of the pro-inflammatory cytokines Interleukin-1β and IL-18, intensifying subsequent inflammatory reactions and promoting OA development. Conversely, the imbalance caused by deacetylase-regulated NLRP3 inflammasome underlies the chronic mild inflammation related to degenerative diseases. Therefore, this article expounds on the mechanism of OA pathogenesis and the role of histone deacetylases (HDACs) in NLRP3 inflammasome-triggered OA, and illustrates the application of HDAC inhibitors in OA, striving to provide more insights into novel OA treatment approaches.https://www.mdpi.com/2079-7737/14/1/71HDACsNLRP3 inflammasomeHDAC inhibitorsosteoarthritischondrocyte pyroptosis
spellingShingle Yuzhou Liu
Ying Wang
Ping Yan
Ning Cui
Kejin Xu
Da Liu
Yuan Tian
Lingling Cao
NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
Biology
HDACs
NLRP3 inflammasome
HDAC inhibitors
osteoarthritis
chondrocyte pyroptosis
title NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
title_full NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
title_fullStr NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
title_full_unstemmed NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
title_short NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
title_sort nlrp3 inflammasome mediated osteoarthritis the role of epigenetics
topic HDACs
NLRP3 inflammasome
HDAC inhibitors
osteoarthritis
chondrocyte pyroptosis
url https://www.mdpi.com/2079-7737/14/1/71
work_keys_str_mv AT yuzhouliu nlrp3inflammasomemediatedosteoarthritistheroleofepigenetics
AT yingwang nlrp3inflammasomemediatedosteoarthritistheroleofepigenetics
AT pingyan nlrp3inflammasomemediatedosteoarthritistheroleofepigenetics
AT ningcui nlrp3inflammasomemediatedosteoarthritistheroleofepigenetics
AT kejinxu nlrp3inflammasomemediatedosteoarthritistheroleofepigenetics
AT daliu nlrp3inflammasomemediatedosteoarthritistheroleofepigenetics
AT yuantian nlrp3inflammasomemediatedosteoarthritistheroleofepigenetics
AT linglingcao nlrp3inflammasomemediatedosteoarthritistheroleofepigenetics